Living with Psoriasis Vulgaris and Multi-Treatment Failure: A Patient and Dermatologist Perspective Riley K. SpencerKareem G. ElhageWilson Liao Commentary Open access 11 March 2023 Pages: 857 - 866
Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel Kim A. PappBarbara MeloskyRonald B. Vender Guidelines Open access 16 March 2023 Pages: 867 - 889
Combination Therapy for Psoriasis with Methotrexate and Other Oral Disease-Modifying Antirheumatic Drugs: A Systematic Review Tyng-Shiuan HsiehTsen-Fang Tsai Review Open access 21 March 2023 Pages: 891 - 909
Paradoxical Reactions to Anti-TNFα and Anti-IL-17 Treatment in Psoriasis Patients: Are Skin and/or Gut Microbiota Involved? Zuzana Jiraskova ZakostelskaZuzana ReissFilip Rob Review Open access 15 March 2023 Pages: 911 - 933
Narrative Review of the Pathogenesis of Stasis Dermatitis: An Inflammatory Skin Manifestation of Venous Hypertension Jonathan SilverbergJ. Mark JacksonUrs Kerkmann Review Open access 22 March 2023 Pages: 935 - 950
Impact of Crisaborole on Sleep Outcomes in Pediatric Patients with Mild-to-Moderate Atopic Dermatitis Joseph FowlerJeffrey SugarmanLiza Takiya Original Research Open access 22 February 2023 Pages: 951 - 960
Similarities and Differences in the Perception of Atopic Dermatitis Burden Between Patients, Caregivers, and Independent Physicians (AD-GAP Survey) Amy S. PallerStephan WeidingerRandy Prescilla Original Research Open access 15 March 2023 Pages: 961 - 980
Factors Predicting Quality of Life Impairment in Adult Patients with Atopic Dermatitis: Results from a Patient Survey and Machine Learning Analysis Carle PaulChristopher E. M. GriffithsMatthias Augustin Original Research Open access 02 March 2023 Pages: 981 - 995
Nemolizumab Improves Patient-Reported Symptoms of Atopic Dermatitis with Pruritus: Post Hoc Analysis of a Japanese Phase III Randomized Controlled Trial Kenji KabashimaTakayo MatsumuraThe Nemolizumab-JP01 Study Group Original Research Open access 11 March 2023 Pages: 997 - 1011
Severity of Local Skin Reactions with 4% 5-Fluorouracil Plus Emollient versus 4% 5-Fluorouracil Alone in Patients with Actinic Keratosis: A Single-Blind Randomised Trial Eggert StockflethThomas JouaryAlain Delarue Original Research Open access 01 March 2023 Pages: 1013 - 1027
Short-Term Effectiveness, Safety, and Potential Predictors of Response of Secukinumab in Patients with Severe Hidradenitis Suppurativa Refractory to Biologic Therapy: A Multicenter Observational Retrospective Study Pablo Fernandez-CrehuetSofía HaselgruberAlejandro Molina-Leyva Original Research Open access 09 March 2023 Pages: 1029 - 1038
Effectiveness of Long-Term Treatment with Brodalumab on Anxiety or Depressive Symptoms in Japanese Patients with Psoriasis: The ProLOGUE Study Chika OhataYasumasa KanaiShinichi Imafuku Original Research Open access 06 March 2023 Pages: 1039 - 1052
Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA Timothy FitzgeraldMaryia ZhdanavaSteven R. Feldman Original Research Open access 16 March 2023 Pages: 1053 - 1068
Correction to: Application of Comfort Therapy under eCASH Concept in Acute and Chronic Wound Treatment Shuting ShiJiayu WeiLihong Zhu Correction Open access 02 March 2023 Pages: 1069 - 1069